Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H27NO.ClH |
Molecular Weight | 345.906 |
Optical Activity | ( - ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=FJQXCDYVZAHXNS-UNTBIKODSA-N
InChI=1S/C21H27NO.ClH/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19;/h6-15,17H,5,16H2,1-4H3;1H/t17-;/m1./s1
DescriptionSources: Helmut Buschmann (20 December 2002). Analgesics: From Chemistry and Pharmacology to Clinical Application. Wiley-VCH. p. 196. ISBN 978-3-527-30403-5. | F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1294. ISBN 978-0-412-46630-4.Curator's Comment: see METHADONE
Sources: Helmut Buschmann (20 December 2002). Analgesics: From Chemistry and Pharmacology to Clinical Application. Wiley-VCH. p. 196. ISBN 978-3-527-30403-5. | F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1294. ISBN 978-0-412-46630-4.
Curator's Comment: see METHADONE
levomethadone, or R-(−)-methadone, is the active enantiomer of methadone; having approximately 50x the potency of the S-(+)-enantiomer as well as greater μ-opioid receptor selectivity.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5084666
Curator's Comment: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/006134s040s041lbl.pdf
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. | 1998 Mar |
|
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. | 2003 Jun |
|
In silico prediction of pregnane X receptor activators by machine learning approaches. | 2007 Jan |
|
[Methadone and levomethadone - dosage and side effects]. | 2014 Mar |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5967-73-7
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | |||
|
227-756-6
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | |||
|
SUB30942
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | |||
|
100000115569
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | |||
|
V57LC776C0
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | |||
|
DTXSID30975070
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | |||
|
m7286
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | Merck Index | ||
|
22266
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | |||
|
236914
Created by
admin on Fri Dec 15 15:25:15 GMT 2023 , Edited by admin on Fri Dec 15 15:25:15 GMT 2023
|
PRIMARY | RxNorm |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD